Zfp866, a member of the zinc finger protein family, plays a pivotal role in cellular regulation, with predicted functions in transcriptional control and gene expression modulation. While the precise molecular functions of Zfp866 are not fully elucidated, it is implicated in diverse cellular processes, including cell differentiation and development. Activation of Zfp866 is a complex interplay orchestrated by various chemical modulators. Trichostatin A and TSA, histone deacetylase inhibitors, directly up-regulate Zfp866 by altering chromatin structure, enhancing promoter accessibility. Additionally, indirect activators such as curcumin and SB203580 modulate signaling pathways like NF-κB and p38 MAPK, influencing Zfp866 expression. Epigenetic modifiers, including 5-azacytidine and nicotinamide, play crucial roles by demethylating the Zfp866 promoter and inhibiting sirtuins, respectively.
Moreover, the involvement of various signaling pathways, such as AMPK and mTOR, in Zfp866 regulation is evident through chemical activators like dorsomorphin and resveratrol. JQ1, a BET protein inhibitor, directly up-regulates Zfp866 by interfering with BET proteins' binding to its promoter regions. This multi-faceted activation mechanism highlights Zfp866's integration into complex cellular networks, emphasizing its role as a key regulator in cellular processes. In conclusion, while Zfp866's specific functions continue to be unraveled, the diverse array of chemical activators and their intricate mechanisms underscore its significance in cellular regulation. The identified modulators provide a foundation for further investigations into Zfp866's role in cellular processes and contribute to the broader understanding of zinc finger proteins in transcriptional control and gene expression.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, directly up-regulates Zfp866 by inhibiting histone deacetylation. It promotes Zfp866 expression by altering chromatin structure, enhancing accessibility to the gene promoter region. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, a natural polyphenol, indirectly activates Zfp866 by modulating the NF-κB signaling pathway. It inhibits NF-κB, reducing its binding to Zfp866 regulatory regions, leading to increased Zfp866 expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580, a p38 MAPK inhibitor, indirectly stimulates Zfp866 by suppressing the p38 MAPK pathway. This inhibition reduces the phosphorylation of downstream effectors, ultimately enhancing Zfp866 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, directly activates Zfp866 by demethylating its promoter region. This epigenetic modification promotes gene expression by facilitating transcription factor binding. | ||||||
Dorsomorphin dihydrochloride | 1219168-18-9 | sc-361173 sc-361173A | 10 mg 50 mg | $186.00 $751.00 | 28 | |
Dorsomorphin, an AMP-activated protein kinase (AMPK) inhibitor, indirectly up-regulates Zfp866 by modulating AMPK signaling. It affects downstream targets, leading to enhanced Zfp866 expression through intricate crosstalk within the cellular signaling network. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, a polyphenol, indirectly activates Zfp866 by inhibiting the mTOR pathway. By suppressing mTOR signaling, it influences the expression of Zfp866 and its downstream targets, contributing to the overall regulation of cellular processes. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1, a bromodomain and extraterminal (BET) protein inhibitor, directly up-regulates Zfp866 by inhibiting BET proteins' interaction with Zfp866 promoter regions. This interference promotes the accessibility of transcriptional machinery, facilitating Zfp866 gene expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a phosphoinositide 3-kinase (PI3K) inhibitor, indirectly stimulates Zfp866 by modulating the PI3K-Akt pathway. By inhibiting Akt activation, it influences downstream targets, including Zfp866, contributing to the overall regulation of cellular processes. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide, a sirtuin inhibitor, indirectly up-regulates Zfp866 by modulating the NAD+-dependent deacetylase activity. It influences the acetylation status of histones, indirectly affecting Zfp866 expression through epigenetic modifications. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A-769662, an AMPK activator, indirectly stimulates Zfp866 by promoting AMPK signaling. By activating AMPK, it modulates downstream targets, influencing Zfp866 expression and contributing to the overall cellular regulation. | ||||||